The São Paulo Patient is no longer HIV-free after more than 15 months off treatment, but was it a relapse or reinfection?

Increased HCV testing and treatment for both HIV-positive and HIV-negative gay and bi men could help eliminate hep C.

A 30-year retrospective review of abnormalities among infants born to women using antiretrovirals shows low, consistent levels.

Study results confirm that dolutegravir is a safe and effective treatment for pregnant women with HIV.

A new simulation suggests that by 2030, multimorbidity in people with HIV will rise substantially.

Long-acting antiretrovirals were the big news at CROI this year; now two of the most promising are joining forces.

A single dose of the HIV capsid inhibitor reduced viral load in highly treatment-experienced people.

At the current pace, only about 20% of the world’s population will be vaccinated by the end of 2021.

HIV-positive people on Medicaid who had gender-affirming surgeries maintained an undetectable viral load, even after the surgeries.

People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.